With growing complexity of post-marketing requirements and commitments in oncology putting strain on the already stretched clinical research ecosystem, real-world research is well suited to bridge the gap between care and research.
In this webinar, experts from The Reagan-Udall Foundation for the FDA, Flatiron Health, and Johnson & Johnson:
- Highlight the value of post-marketing studies and key frameworks for efficient and impactful evidence generation
- Present an overview of PMR/PMCs in oncology and opportunities for real-world evidence generation approaches
- Share examples of more pragmatic approaches to PMR/PMCs
Learn more about our evidence solutions
